Funding is essential for the successful execution of clinical trials, which are critical for testing new cancer therapies. These trials require substantial investment due to their complexity and the need for rigorous safety and efficacy testing. Insufficient funding can delay or halt trials, potentially delaying the availability of effective new treatments to patients.
